Corey N. Fishman
CIK 1553594 · Chief Executive Officer · last filed 2024-08-12
Corey N. Fishman is a Chief Executive Officer who has filed 22 SEC Form 4 insider transactions across 4 companies since 2012. The most recent filing, for ITRM, was dated Aug 12, 2024. Across all open-market trades the lifetime net is −$75.5K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
4
22
-$75.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Iterum Therapeutics plc (ITRM) Delisted | Chief Executive Officer | 137,062 | $0.03 | $4.1K | -$75.5K | 12 | 2024-08-12 |
| BIOSPECIFICS TECHNOLOGIES CORP (BSTC) Delisted | Director | 0 | — | — | $0 | 3 | 2020-12-02 |
| MOMENTA PHARMACEUTICALS INC (MNTA) Delisted | Director | 10,090 | — | — | $0 | 4 | 2019-06-21 |
| Durata Therapeutics, Inc. (DRTX) Delisted | CFO&COO | 0 | — | — | $0 | 3 | 2014-11-18 |
Recent Filings
22 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-08-12 | Iterum Therapeutics plc (ITRM) Delisted | Exer (M) | +82,613 | $0 | EDGAR |
| 2023-11-20 | Iterum Therapeutics plc (ITRM) Delisted | Buy (P) | +10,000 | $15.9K | EDGAR |
| 2023-04-03 | Iterum Therapeutics plc (ITRM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-03-14 | Iterum Therapeutics plc (ITRM) Delisted | Mixed | +8,650 | -$5.5K | EDGAR |
| 2022-03-15 | Iterum Therapeutics plc (ITRM) Delisted | Exer (M) | +215,000 | $0 | EDGAR |
| 2021-06-25 | Iterum Therapeutics plc (ITRM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-03-15 | Iterum Therapeutics plc (ITRM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-01-27 | Iterum Therapeutics plc (ITRM) Delisted | Mixed | +82,055 | -$147.8K | EDGAR |
| 2020-12-02 | BIOSPECIFICS TECHNOLOGIES CORP (BSTC) Delisted | Disp (D) | −2,018 | $0 | EDGAR |
| 2020-05-04 | BIOSPECIFICS TECHNOLOGIES CORP (BSTC) Delisted | Grant (A) | — | $0 | EDGAR |